Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
NA
This study is a prospective, single-arm, single-center trial evaluating the...
EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial
PHASE1
The goal of this clinical trial is to evaluate the efficacy and safety of c...
Status
Not Yet Recruiting
Location
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery
Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors
PHASE2
This is a monocenter, single-arm, open-label study to evaluate the efficacy...